Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Oral Oncology|December 30, 2015
Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancerNeil M Woody, Shlomo A Koyfman, Ping Xia, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinomaThomas W Rice, Eugene H Blackstone, David J Adelstein, et al.
The Laryngoscope|April 10, 2009
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?C Arturo Solares, Benjamin Wood, Cristina P Rodriguez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database AnalysisNeil M Woody, Matthew C Ward, Shlomo A Koyfman, et al.
Head & Neck|August 13, 2009
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinomaSteven B Cannady, Walter T Lee, Joseph Scharpf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2009
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junctionDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Head & Neck|February 12, 2017
Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancerMichael A Weller, Matthew C Ward, Camille Berriochoa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancerCristina P Rodriguez, David J Adelstein, Thomas W Rice, et al.
Anticancer Research|February 7, 2016
Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative RadiotherapyAnisha R Noble, John F Greskovich, Jaehong Han, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Oral Oncology|December 30, 2015
Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancerNeil M Woody, Shlomo A Koyfman, Ping Xia, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinomaThomas W Rice, Eugene H Blackstone, David J Adelstein, et al.
The Laryngoscope|April 10, 2009
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?C Arturo Solares, Benjamin Wood, Cristina P Rodriguez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database AnalysisNeil M Woody, Matthew C Ward, Shlomo A Koyfman, et al.
Head & Neck|August 13, 2009
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinomaSteven B Cannady, Walter T Lee, Joseph Scharpf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2009
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junctionDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Head & Neck|February 12, 2017
Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancerMichael A Weller, Matthew C Ward, Camille Berriochoa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancerCristina P Rodriguez, David J Adelstein, Thomas W Rice, et al.
Anticancer Research|February 7, 2016
Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative RadiotherapyAnisha R Noble, John F Greskovich, Jaehong Han, et al.
Pageof 11